Gastroenterology Issues in Schizophrenia: Why the Gut Matters
- 1.1k Downloads
Genetic and environmental studies implicate immune pathologies in schizophrenia. The body’s largest immune organ is the gastrointestinal (GI) tract. Historical associations of GI conditions with mental illnesses predate the introduction of antipsychotics. Current studies of antipsychotic-naïve patients support that gut dysfunction may be inherent to the schizophrenia disease process. Risk factors for schizophrenia (inflammation, food intolerances, Toxoplasma gondii exposure, cellular barrier defects) are part of biological pathways that intersect those operant in the gut. Central to GI function is a homeostatic microbial community, and early reports show that it is disrupted in schizophrenia. Bioactive and toxic products derived from digestion and microbial dysbiosis activate adaptive and innate immunity. Complement C1q, a brain-active systemic immune component, interacts with gut-related schizophrenia risk factors in clinical and experimental animal models. With accumulating evidence supporting newly discovered gut–brain physiological pathways, treatments to ameliorate brain symptoms of schizophrenia should be supplemented with therapies to correct GI dysfunction.
KeywordsMicrobiome Autoimmunity Blood–brain barrier Gluten Autism Synapses
Compliance with Ethics Guidelines
Conflict of Interest
James Castiglione declares that he has no conflict of interest.
Emily G. Severance reports that this work was supported by a NIMH P50 Silvio O. Conte Center at Johns Hopkins (grant no. MH-94268) and by the Stanley Medical Research Institute. Dr. Severance also has received a grant from the Brain & Behavior Research Foundation (NARSAD) and has received support for travel to meetings from the Stanley Medical Research Institute.
Emese Prandovszky has received a grant and support for travel to meetings from the Stanley Medical Research Institute.
Robert H. Yolken reports that this work was supported by a NIMH P50 Silvio O. Conte Center at Johns Hopkins (grant no. MH-94268) and by the Stanley Medical Research Institute. Dr. Yolken is a board member and has received travel support from the Stanley Medical Research Institute.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 1.APA. Diagnostic and Statistical Manual of Mental Disorders, 5th edition: DSM-5. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.Google Scholar
- 10.••The Network and Pathway Analysis Subgroup of the Psychiatric Genomics Consortium. Psychiatric genome-wide association study analyses implicate neuronal, immune and histone pathways. Nat Neurosci. 2015. doi: 10.1038/nn.3922. These investigators analysed the most currently available genetic data from GWAS studies of schizophrenia in the context of biological pathway interactions and found strong associations of DNA methylation, immune system, and neuronal signalling processes.
- 11.APA. Diagnostic and Statistical Manual of Mental Disorders (DSM-I). 1st ed. Washington, D.C.: American Psychiatric Association; 1952.Google Scholar
- 12.WHO. Manual of the international statistical classification of diseases, injuries and causes of death. Geneva: World Health Organization; 1949.Google Scholar
- 15.Severance EG, Gressitt KL, Stallings CR, Origoni AE, Khushalani S, Leweke FM, et al. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia. Schizophr Res. 2013;148(1–3):130–7. doi: 10.1016/j.schres.2013.05.018.PubMedCentralPubMedGoogle Scholar
- 23.APA. The American Journal of Insanity. American Journal of Psychiatry. 1844;1(October):97–192.Google Scholar
- 24.Earle P, APA. Contributions to the pathology of insanity. Am J Insanity. 1846;3(1):35–40.Google Scholar
- 25.Allen JR. On the treatment of insanity. Am J Insanity. 1850;6(January):263–83.Google Scholar
- 26.Woodward SB. Observations on the medical treatment of insanity. Am J Insanity. 1850;7(July):1–29.Google Scholar
- 27.Bucknill JC. On the pathology of insanity. Am J Insanity. 1857;14(July):29, 172, 254, 348Google Scholar
- 28.Gray JP. The dependence of insanity on physical disease. Am J Insanity. 1871;27(April):317–408.Google Scholar
- 29.Workman J. Certain abdominal lesions in the insane. Am J Insanity. 1863;20:44–60.Google Scholar
- 30.Deecke T. Condition of the brain in insanity. Am J Insanity. 1881;37:361–92.Google Scholar
- 31.Cowles E. Notes and comments. Am J Insanity. 1903;60Google Scholar
- 32.Herter, C.A. (1907) The common bacterial infections of the digestive tract and the intoxications arising from them. The Macmillan Company, New York, and LondonGoogle Scholar
- 48.Buscaino V. Patologia extraneurale della schizofrenia. Fegato, tubo digerente, sistema reticolo-endoteliale. Acta neurologica 1953;VIII:1–60.Google Scholar
- 49.Hemmings G. Schizophrenia. Lancet. 2004;364(9442):1312–3. doi: 10.1016/S0140-6736(04)17181-X.
- 50.Desplat-Jego S, Johanet C, Escande A, Goetz J, Fabien N, Olsson N, et al. Update on anti-Saccharomyces cerevisiae antibodies, anti-nuclear associated anti-neutrophil antibodies and antibodies to exocrine pancreas detected by indirect immunofluorescence as biomarkers in chronic inflammatory bowel diseases: results of a multicenter study. World J Gastroenterol. 2007;13(16):2312–8.Google Scholar
- 52.Cascella NG, Kryszak D, Bhatti B, Gregory P, Kelly DL, Mc Evoy JP, et al. Prevalence of celiac disease and gluten sensitivity in the United States clinical antipsychotic trials of intervention effectiveness study population. Schizophr Bull. 2011;37(1):94–100. doi: 10.1093/schbul/sbp055.PubMedCentralPubMedGoogle Scholar
- 55.Dohan FC. Wheat “consumption” and hospital admissions for schizophrenia during World War II. A preliminary report. Am J Clin Nutr. 1966;18(1):7–10.Google Scholar
- 57.Reichelt KL, Seim AR, Reichelt WH. Could schizophrenia be reasonably explained by Dohan’s hypothesis on genetic interaction with a dietary peptide overload? Prog Neuro-Psychopharmacol Biol Psychiatry. 1996;20(7):1083–114.Google Scholar
- 67.••Hsiao EY, McBride SW, Hsien S, Sharon G, Hyde ER, McCue T, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell. 2013;155(7):1451–63. doi: 10.1016/j.cell.2013.11.024. This study in mice was among the first contemporary investigations to link maternal immune activation with brain processes in offspring through a gut microbiome mechanism.PubMedCentralPubMedGoogle Scholar
- 75.Soderholm JD, Perdue MH. Stress and gastrointestinal tract II. Stress and intestinal barrier function. Am J Physiol Gastrointest Liver Physiol. 2001;280(1):G7–G13.Google Scholar
- 78.Zeissig S, Burgel N, Gunzel D, Richter J, Mankertz J, Wahnschaffe U, et al. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn’s disease. Gut. 2007;56(1):61–72. doi: 10.1136/gut.2006.094375.PubMedCentralPubMedGoogle Scholar
- 83.Mortensen PB, Norgaard-Pedersen B, Waltoft BL, Sorensen TL, Hougaard D, Torrey EF, et al. Toxoplasma gondii as a risk factor for early-onset schizophrenia: analysis of filter paper blood samples obtained at birth. Biol Psychiatry. 2007;61(5):688–93. doi: 10.1016/j.biopsych.2006.05.024.PubMedGoogle Scholar
- 85.•Hand TW, Dos Santos LM, Bouladoux N, Molloy MJ, Pagan AJ, Pepper M, et al. Acute gastrointestinal infection induces long-lived microbiota-specific T cell responses. Science. 2012;337(6101):1553–6. doi: 10.1126/science.1220961. Results from this rodent model provided a mechanism by which GI infection causes immune pathologies such as loss of tolerance to commensals and activation of T cells that were specific to microbiota groups. Interestingly, T. gondii was used to induce the GI infection.PubMedCentralPubMedGoogle Scholar
- 89.Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG. Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J Psychiatr Res. 2010;44(5):321–30. doi: 10.1016/j.jpsychires.2009.08.008.PubMedGoogle Scholar
- 97.Sindhu KN, Sowmyanarayanan TV, Paul A, Babji S, Ajjampur SS, Priyadarshini S, et al. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2014;58(8):1107–15. doi: 10.1093/cid/ciu065.PubMedCentralPubMedGoogle Scholar
- 99.••Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Toth M, et al. The gut microbiota influences blood–brain barrier permeability in mice. Sci Transl Med. 2014;6(263):263ra158. doi: 10.1126/scitranslmed.3009759. This rodent study tests and verifies a mechanistic link between the gut microbiota and integrity of the blood–brain barrier.PubMedCentralPubMedGoogle Scholar
- 101.••Stevens B, Allen NJ, Vazquez LE, Howell GR, Christopherson KS, Nouri N, et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131(6):1164–78. doi: 10.1016/j.cell.2007.10.036. This important study showed that complement C1q, a well-characterized peripheral immune factor, functions in the CNS to tag unwanted synapses for removal.PubMedGoogle Scholar
- 102.••Huh GS, Boulanger LM, Du H, Riquelme PA, Brotz TM, Shatz CJ. Functional requirement for class I MHC in CNS development and plasticity. Science. 2000;290(5499):2155–9. Classic immune molecules such as MHC function to form and remodel synapses in the developing and mature brain.Google Scholar
- 115.••Yolken RH, Severance EG, Sabunciyan S, Gressitt KL, Chen O, Stallings C et al. Metagenomic sequencing indicates that the oropharyngeal phageome of individuals with schizophrenia differs from that of controls. Schizophrenia Bulletin. 2015, In Press. This study of humans is one of the first to show that individuals with schizophrenia have an altered microbiome compared to controls.Google Scholar
- 122.Dickerson FB, Stallings C, Origoni A, Katsafanas E, Savage CL, Schweinfurth LA et al. Effect of probiotic supplementation on schizophrenia symptoms and association with gastrointestinal functioning: a randomized, placebo-controlled trial. Prim Care Companion CNS Disord. 2014;16(1). doi: 10.4088/PCC.13m01579